Patents by Inventor Rolf Dach

Rolf Dach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8993778
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: March 31, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
  • Patent number: 8993770
    Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: March 31, 2015
    Assignee: Boehringer Ingelheim International GbmH
    Inventors: Frieder Gnad, Stefan Schmitt, Hermann Mueller-Boetticher, Helmut Heitger, Seigfried Meineck, Rolf Dach, Ingo Heddesheimer
  • Publication number: 20130303760
    Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.
    Type: Application
    Filed: July 18, 2013
    Publication date: November 14, 2013
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
    Inventors: Rolf DACH, Xiangrui JIANG, Jingshan SHEN, Jin SUO, Yi ZHU
  • Patent number: 8513413
    Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: August 20, 2013
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Rolf Dach, Xiangrui Jiang, Jingshan Shen, Jin Suo, Yi Zhu
  • Publication number: 20130158270
    Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.
    Type: Application
    Filed: February 15, 2013
    Publication date: June 20, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Frieder GNAD, Stefan SCHMITT, Hermann MUELLER-BOETTICHER, Helmut HEITGER, Seigfried MEINECK, Rolf DACH, Ingo HEDDESHEIMER
  • Publication number: 20130137878
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.
    Type: Application
    Filed: January 25, 2013
    Publication date: May 30, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Norbert HAUEL, Rolf DACH, Helmut HEITGER, Oliver MEYER
  • Patent number: 8399678
    Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: March 19, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frieder Gnad, Stefan Schmitt, Hermann Mueller-Boetticher, Helmut Heitger, Siegfried Meineck, Rolf Dach, Ingo Heddesheimer
  • Patent number: 8263788
    Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: September 11, 2012
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
  • Publication number: 20120123118
    Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.
    Type: Application
    Filed: February 22, 2010
    Publication date: May 17, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH & CO. KG
    Inventors: Rolf Dach, Xiangrui Jiang, Jingshan Shen, Jin Suo, Yi Zhu
  • Publication number: 20110275824
    Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.
    Type: Application
    Filed: November 4, 2010
    Publication date: November 10, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Frieder GNAD, Stefan SCHMITT, Hermann MUELLER-BOETTICHER, Helmut HEITGER, Siegfried MEINECK, Rolf DACH, Ingo HEDDESHEIMER
  • Publication number: 20100305146
    Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.
    Type: Application
    Filed: September 3, 2008
    Publication date: December 2, 2010
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
    Inventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
  • Patent number: 7608722
    Abstract: A process for preparing 1,7?-dimethyl-2?-propyl-2,5?-bi-1H-benzimidazole of formula (I) reacting N-methyl-o-phenylenediamine of formula (II) or the salts thereof with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid of formula (III) or the salts thereof wherein the coupling and cyclization is achieved using 1,3,5-triazine and tertiary amine.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: October 27, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Helmut Heitger, Juan M. Rodriguez-Dehli, Rolf Dach
  • Patent number: 7193089
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: March 20, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
  • Publication number: 20070037986
    Abstract: A process for preparing 1,7?-dimethyl-2?-propyl-2,5?-bi-1H-benzimidazole of formula (I) reacting N-methyl-o-phenylenediamine of formula (II) or the salts thereof with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid of formula (III) or the salts thereof wherein the coupling and cyclization is achieved using 1,3,5-triazine and tertiary amine.
    Type: Application
    Filed: July 12, 2006
    Publication date: February 15, 2007
    Inventors: Helmut Heitger, Juan Rodriguez-Dehli, Rolf Dach
  • Publication number: 20040236113
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1′-methylbenzimidazol-2′-yl)benzimidazole with a compound of formula (IV) 1
    Type: Application
    Filed: March 17, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
  • Publication number: 20040225129
    Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 11, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
  • Patent number: 6770762
    Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: August 3, 2004
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
  • Publication number: 20030139608
    Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.
    Type: Application
    Filed: January 16, 2003
    Publication date: July 24, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
  • Patent number: 6403790
    Abstract: A process for preparing epinastine hydrochloride of formula (I) the process comprising: (a) suspending and dissolving an epinastine base of formula (II)  in water by the addition of aqueous hydrochloric acid at a pH of ≧7; (b) extracting the aqueous solution obtained from step (a) with an organic, water-immiscible solvent; (c) removing the organic, water-immiscible solvent from the aqueous solution obtained from step (b); and (d) adjusting the pH of the aqueous solution of step (c) to ≦6 using hydrochloric acid to precipitate the product of formula (I), and then drying the product.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: June 11, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventor: Rolf Dach
  • Patent number: 5510484
    Abstract: The present invention relates to an improved process for preparing 1,3-dimethyl-4,5-diaminouracil by catalytic reduction of 1,3-dimethyl-4-amino-5-nitrosouracil in the presence of a palladium/charcoal catalyst.
    Type: Grant
    Filed: April 7, 1994
    Date of Patent: April 23, 1996
    Assignee: Boehringer Ingelheim KG
    Inventors: Rolf Dach, Wilfried Goldschmidt